MediciNova 8-K 2015
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 1, 2015
(Exact name of registrant as specified in its charter)
Registrants telephone number, including area code: (858) 373-1500
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
On September 1, 2015 (Japanese Standard Time), MediciNova, Inc. (the Company) issued a press release noting that FMR LLC had filed with the Kanto Local Finance Bureau a report stating that it acquired 3,507,800 shares of the Companys Common Stock, constituting 11.73% of the outstanding Common Stock. In its report, FMR LLC stated that it did not anticipate its ownership would have any effect upon the Companys management or performance.
The information in this Current Report is being furnished and shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that Section. The information in this Current Report shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: September 1, 2015